1. Home
  2. SAR vs KMDA Comparison

SAR vs KMDA Comparison

Compare SAR & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAR
  • KMDA
  • Stock Information
  • Founded
  • SAR 2007
  • KMDA 1990
  • Country
  • SAR United States
  • KMDA Israel
  • Employees
  • SAR N/A
  • KMDA N/A
  • Industry
  • SAR Investment Managers
  • KMDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • SAR Finance
  • KMDA Health Care
  • Exchange
  • SAR Nasdaq
  • KMDA Nasdaq
  • Market Cap
  • SAR 337.6M
  • KMDA 399.7M
  • IPO Year
  • SAR 2007
  • KMDA N/A
  • Fundamental
  • Price
  • SAR $24.44
  • KMDA $7.20
  • Analyst Decision
  • SAR Hold
  • KMDA Strong Buy
  • Analyst Count
  • SAR 4
  • KMDA 3
  • Target Price
  • SAR $24.75
  • KMDA $14.67
  • AVG Volume (30 Days)
  • SAR 133.5K
  • KMDA 71.8K
  • Earning Date
  • SAR 07-08-2025
  • KMDA 08-13-2025
  • Dividend Yield
  • SAR 13.60%
  • KMDA 2.77%
  • EPS Growth
  • SAR 186.33
  • KMDA 31.21
  • EPS
  • SAR 2.02
  • KMDA 0.28
  • Revenue
  • SAR $148,855,238.00
  • KMDA $167,235,000.00
  • Revenue This Year
  • SAR N/A
  • KMDA $14.51
  • Revenue Next Year
  • SAR $2.28
  • KMDA $9.31
  • P/E Ratio
  • SAR $12.13
  • KMDA $26.07
  • Revenue Growth
  • SAR 3.57
  • KMDA 11.83
  • 52 Week Low
  • SAR $21.10
  • KMDA $4.74
  • 52 Week High
  • SAR $26.49
  • KMDA $9.16
  • Technical
  • Relative Strength Index (RSI)
  • SAR 50.58
  • KMDA 65.83
  • Support Level
  • SAR $24.05
  • KMDA $6.78
  • Resistance Level
  • SAR $24.44
  • KMDA $7.09
  • Average True Range (ATR)
  • SAR 0.33
  • KMDA 0.16
  • MACD
  • SAR -0.03
  • KMDA 0.04
  • Stochastic Oscillator
  • SAR 45.16
  • KMDA 98.48

About SAR Saratoga Investment Corp New

Saratoga Investment Corp is a specialty finance company that provides customized financing solutions to U.S. middle-market businesses. The Company invests primarily in senior and unitranche leveraged loans and mezzanine debt, and, to a lesser extent, equity to provide financing for change of ownership transactions, strategic acquisitions, recapitalizations and growth initiatives in partnership with business owners, management teams and financial sponsors. Its objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from its debt and equity investments.

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Share on Social Networks: